Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEFinancialsInsurance - SpecialtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.50 → 2.42 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for EIG yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain and increase dividend payments to at least $0.34 per share quarterly | Employers Holdings keeps paying and raising dividends, now $0.34 per share. | Intact | dividend per share falls below $0.32 per share quarterly | Dividend per share: $0.34 per share FY2026-Q3; GAAP. Published target: >= $0.34 per share quarterly. Target period is not explicitly aligned with this observation. Oct 30, 20260.34 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
EIG is a financial company with an underwriting recovery thesis, rather than a proven durable compounder. The multi-year view remains intact, but execution is mixed: recent results improved while underwriting is still unprofitable.
The valuation evidence points to EIG being cheap versus peers, with low model confidence and a positive expectations gap. At the same time, the priced-in assessment flags elevated fragility because of expensive valuation and weak execution quality, so the evidence on what the market assumes is mixed.
Near term, recent earnings beats and stronger company momentum support a better operating picture, but the combined ratio remains above 100% and gross premiums written declined. Management continues to emphasize disciplined underwriting and has made early progress in workers’ compensation products, while capital returns remain on track.
The multi-year thesis hinges on whether underwriting discipline can bring the combined ratio below 100% without further weakening premium volume. Near term, a guidance cut would be a meaningful negative, while sustained strength among sector bellwethers could support momentum; rate cuts are another stated sector risk.
For the next 1 to 3 years, EIG presents an intact but fragile underwriting recovery thesis, with recent improvement offset by continued underwriting losses and thinner premium volume. The main test is whether execution turns that improvement into sustained underwriting profitability. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Grow EPS to at least $2.32 in fiscal 2026 |
| Earnings per share are expected to grow to $2.32 in 2026. |
| Intact |
| EPS falls below $2.0 in fiscal 2026 |
Diluted EPS: $0.64 per share FY2026-Q3; GAAP. Published target: >= $2.32 EPS. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Oct 30, 20260.64 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Limit revenue decline to no worse than -7% in next 12 months | A supporting condition in Employers Holdings, Inc.'s published investment case. The stated target is >= -7% YoY revenue growth. | Intact | revenue decline exceeds -7% YoY | Revenue growth: -20.89% FY2026-Q3; GAAP. Published target: >= -7% YoY revenue growth. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Oct 30, 2026-20.894275 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Execute $125 million share repurchase program from May 2026 through December 2027 | They have a $125 million share buyback program underway. | Intact | repurchases fall short of $125 million by end 2027 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.51 → $2.42 · observed estimates
$0.78B → $0.74B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.51 | $781,523,500 | 2 / 1 |
| 2026-07-25 | $2.57 | $781,523,500 | 3 / 2 |
| 2026-07-26 | $2.57 | $781,523,500 | 3 / 2 |
| 2026-07-27 | $2.57 | $781,523,500 | 3 / 2 |
| 2026-07-28 | $2.57 | $781,523,500 | 3 / 2 |
| 2026-07-29 | $2.57 | $781,523,500 | 3 / 2 |
| 2026-07-30 | $2.57 | $781,523,500 | 3 / 2 |
| 2026-07-31 | $2.51 | $781,523,500 | 2 / 1 |
| 2026-08-01 | $2.51 | $781,523,500 | 2 / 1 |
| 2026-08-02 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-03 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-04 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-05 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-06 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-07 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-08 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-09 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-10 | $2.57 | $756,813,500 | 3 / 2 |
| 2026-08-11 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-12 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-13 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-14 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-15 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-16 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-17 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-18 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-19 | $2.51 | $756,813,500 | 2 / 1 |
| 2026-08-20 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-21 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-22 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-23 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-24 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-25 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-26 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-27 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-28 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-29 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-30 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-08-31 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-01 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-02 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-03 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-04 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-05 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-06 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-07 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-08 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-09 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-10 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-11 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-12 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-13 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-14 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-15 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-16 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-17 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-18 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-19 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-20 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-21 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-22 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-23 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-24 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-25 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-26 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-27 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-28 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-29 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-09-30 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-01 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-02 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-03 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-04 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-05 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-06 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-07 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-08 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-09 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-10 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-11 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-12 | $2.50 | $733,013,500 | 2 / 1 |
| 2026-10-13 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-14 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-15 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-16 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-17 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-18 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-19 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-20 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-21 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-22 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-23 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-24 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-25 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-26 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-27 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-28 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-29 | $2.47 | $733,013,500 | 2 / 1 |
| 2026-10-30 | $2.42 | $733,013,500 | 2 / 1 |
| 2026-10-31 | $2.42 | $737,366,500 | 2 / 1 |
| 2026-11-01 | $2.42 | $737,366,500 | 2 / 1 |
| 2026-11-02 | $2.42 | $737,366,500 | 2 / 1 |
| 2026-11-03 | $2.42 | $737,366,500 | 2 / 1 |
| 2026-11-04 | $2.42 | $737,366,500 | 2 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.